Log in or Sign up for Free to view tailored content for your specialty!
Surgery News
Risk score may predict need for pacemaker after TAVR
Researchers have developed and validated the Emory risk score as a tool for predicting patients’ need for pacemaker implantation after transcatheter aortic valve replacement, according to findings published in JACC: Cardiovascular Intervention.
Peripheral stent beneficial in common femoral artery stenosis at 2 years
LAS VEGAS — A repuncturable vascular mimetic peripheral stent system was safe and effective at 2 years in patients with common femoral artery disease, according to new data from the VMI-CFA study.
Log in or Sign up for Free to view tailored content for your specialty!
Risk for endocarditis similar in TAVR, surgical AVR
The predictors, incidence or risk for prosthetic valve endocarditis were similar in patients with severe aortic stenosis regardless of whether they underwent transcatheter aortic valve replacement or surgical AVR, according to a cohort study of patients from PARTNER I and PARTNER II trials published in Circulation.
FDA designates recall of circulatory support system as Class 1
The FDA has designated Abbott’s product recall of a circulatory support system as a Class 1 recall, the most serious kind. The recall affects 381 devices distributed between Nov. 22, 2017 and Aug. 6, 2019.
FDA grants fast track status to ASP1128 for patients at risk for AKI
The FDA has granted fast track designation for development of ASP1128, an investigational compound by Astellas Pharma Inc. for patients at risk of developing acute kidney injury after coronary artery bypass or valve surgery, according to a company press release.
Cardiac rehabilitation enrollment after surgery low despite benefits
Cardiac rehabilitation is linked to a decreased risk for 1-year cumulative hospitalization and mortality risk in Medicare beneficiaries after cardiac valve surgery, but fewer than half of these patients were enrolled in a program, according to a study published in JAMA Cardiology.
PARTNER 3: TAVR improves quality of life compared with surgery
SAN FRANCISCO — Compared with patients assigned surgery, those assigned transcatheter aortic valve replacement had a better Kansas City Cardiomyopathy Questionnaire-Overall Summary, or KCCQ-OS, score at 1 month, 6 months and 12 months, according to new data from the PARTNER 3 trial presented at TCT 2019.
Substance use disorder increases mortality risk after endocarditis surgery
High rates of morbidity and mortality after valve replacement surgery were seen in patients with substance use disorder-related infective endocarditis, according to a study published in the Annals of Thoracic Surgery.
THEMIS, TWILIGHT, other major trials spotlighted at CMHC
CHICAGO — Healio presents live updates from the late-breaking trials session at the Cardiometabolic Health Congress.
Greater operator, hospital mitral valve surgery volume tied to reduced mortality, more repair
SAN FRANCISCO — Higher operator and hospital volume conferred better results for 30-day operative mortality, successful repair of primary mitral regurgitation and 1-year mortality, according to a presentation at TCT 2019.